{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:14:01Z","timestamp":1793459641736,"version":"4.5.0"},"reference-count":82,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":117,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Gordie Howe CARES"},{"name":"Evans Family fund via the Hotchkiss Brain Institute"},{"DOI":"10.13039\/100013053","name":"Hotchkiss Brain Institute, Killam Trust, Alzheimer Society of Canada, and Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013053","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UK National Institute for Health and Care Research Exeter Biomedical Research Centre"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Subjective cognitive decline and mild behavioural impairment identify older persons more likely to have early Alzheimer\u2019s disease. Vascular co-pathologies may also contribute to new onset and persistent cognitive and behavioural symptoms later in life. We investigated vascular risk factor associations with subjective cognitive decline and mild behavioural impairment. Cross-sectional data for 1285 (81.0% female) participants without mild cognitive impairment or dementia enrolled in the Canadian Platform for Research Online to Investigate Health, Quality of Life, Cognition, Behaviour, Function, and Caregiving in Aging were analyzed. Vascular risk factors included body mass index class, self-reported clinician diagnoses of hypertension, high cholesterol, diabetes, self-reported smoking, and the cumulative number of vascular risk factors. Outcomes were the Everyday Cognition scale and Mild Behavioural Impairment Checklist. Logistic and negative binomial regressions were used to model odds and severity of subjective cognitive decline and mild behavioural impairment as a function of individual or cumulative vascular risk factors. Having three or more vascular risk factors (odds ratio = 1.23, 95% confidence interval [1.04\u20131.47]), actively smoking (odds ratio = 1.54, 95% confidence interval [1.29\u20131.82]), being overweight (odds ratio = 1.46, 95% confidence interval [1.22\u20131.74]), and having diabetes (odds ratio = 1.29, 95% confidence interval [1.09\u20131.53]) were associated with higher odds of subjective cognitive decline. Having any number of vascular risk factors was dose-dependently associated with higher odds of mild behavioural impairment, as were all five vascular risk factors individually; active smokers (odds ratio = 2.67, 95% confidence interval [2.25\u20133.18]) and obese persons (odds ratio = 2.29, 95% confidence interval [1.91\u20132.75]) had over twice the odds of mild behavioural impairment. Vascular risk factors associations with subjective cognitive decline were stronger in participants with mild behavioural impairment. All vascular risk factors were linked to higher Everyday Cognition and Mild Behavioural Impairment Checklist total scores, indicating greater subjective cognitive decline and mild behavioural impairment symptom severity. Overweight body mass index, hypertension, and high cholesterol associations with subjective cognitive decline and mild behavioural impairment were stronger in middle-aged adults than older adults, but diabetes and active smoking had greater effects in older adults. Vascular risk factors are strongly related to experiences of cognitive and behavioural changes in later life, even in the absence of objective cognitive impairment. Furthermore, vascular associations with subjective cognitive decline symptoms may be more pronounced in persons with concomitant behavioural decline. Vascular pathologies may contribute to both cognitive and behavioural markers traditionally linked to Alzheimer\u2019s disease in older persons, prior to mild cognitive impairment and dementia.<\/jats:p>","DOI":"10.1093\/braincomms\/fcaf163","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T15:55:29Z","timestamp":1745855729000},"source":"Crossref","is-referenced-by-count":13,"title":["Vascular risk factor associations with subjective cognitive decline and mild behavioural impairment"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7065-1963","authenticated-orcid":false,"given":"Dylan X","family":"Guan","sequence":"first","affiliation":[{"name":"Cumming School of Medicine, University of Calgary , Calgary ,","place":["Canada, T2N4N1"]},{"name":"Hotchkiss Brain Institute, University of Calgary , Calgary ,","place":["Canada, T2N4N1"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Aundhakar","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, University of Calgary , Calgary ,","place":["Canada, T2N4N1"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Tomaszewski Farias","sequence":"additional","affiliation":[{"name":"Department of Neurology, Davis School of Medicine, University of California , Sacramento 95817 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0022-5632","authenticated-orcid":false,"given":"Clive","family":"Ballard","sequence":"additional","affiliation":[{"name":"Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter , Exeter EX44QJ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron","family":"Creese","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, College of Health Medicine and Life Sciences, Brunel University London , London UB83PH ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2015-0316","authenticated-orcid":false,"given":"Anne","family":"Corbett","sequence":"additional","affiliation":[{"name":"Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter , Exeter EX44QJ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellie","family":"Pickering","sequence":"additional","affiliation":[{"name":"Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter , Exeter EX44QJ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Roach","sequence":"additional","affiliation":[{"name":"Cumming School of Medicine, University of Calgary , Calgary ,","place":["Canada, T2N4N1"]},{"name":"Hotchkiss Brain Institute, University of Calgary , Calgary ,","place":["Canada, T2N4N1"]},{"name":"Department of Family Medicine, University of Calgary , Calgary ,","place":["Canada, T2N4N1"]},{"name":"Department of Community Health Sciences, University of Calgary , Calgary ,","place":["Canada, T2N4N1"]},{"name":"O\u2019Brien Institute for Public Health, University of Calgary , Calgary ,","place":["Canada, T2N4N1"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric E","family":"Smith","sequence":"additional","affiliation":[{"name":"Cumming School of Medicine, University of Calgary , Calgary ,","place":["Canada, T2N4N1"]},{"name":"Hotchkiss Brain Institute, University of Calgary , Calgary ,","place":["Canada, T2N4N1"]},{"name":"Department of Clinical Neurosciences, University of Calgary , Calgary ,","place":["Canada, T2N4N1"]},{"name":"Department of Community Health Sciences, University of Calgary , Calgary ,","place":["Canada, T2N4N1"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5529-3731","authenticated-orcid":false,"given":"Zahinoor","family":"Ismail","sequence":"additional","affiliation":[{"name":"Cumming School of Medicine, University of Calgary , Calgary ,","place":["Canada, T2N4N1"]},{"name":"Hotchkiss Brain Institute, University of Calgary , Calgary ,","place":["Canada, T2N4N1"]},{"name":"Department of Clinical Neurosciences, University of Calgary , Calgary ,","place":["Canada, T2N4N1"]},{"name":"Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter , Exeter EX44QJ ,","place":["UK"]},{"name":"Department of Community Health Sciences, University of Calgary , Calgary ,","place":["Canada, T2N4N1"]},{"name":"O\u2019Brien Institute for Public Health, University of Calgary , Calgary ,","place":["Canada, T2N4N1"]},{"name":"Department of Psychiatry, University of Calgary , Calgary ,","place":["Canada, T2N4N1"]},{"name":"Department of Pathology and Laboratory Medicine, University of Calgary , Calgary ,","place":["Canada, T2N4N1"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"issue":"2","key":"2025052523413235500_fcaf163-B1","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the global burden of disease study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health."},{"issue":"2","key":"2025052523413235500_fcaf163-B2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3233\/JAD-2011-110359","article-title":"Why have we failed to cure Alzheimer's disease?","volume":"29","author":"Korczyn","year":"2012","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"2025052523413235500_fcaf163-B3","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1474-4422(11)70072-2","article-title":"The projected effect of risk factor reduction on Alzheimer's disease prevalence","volume":"10","author":"Barnes","year":"2011","journal-title":"Lancet Neurol"},{"issue":"5","key":"2025052523413235500_fcaf163-B4","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.14283\/jpad.2024.105","article-title":"Potentially modifiable dementia risk factors in Canada: An analysis of Canadian longitudinal study on aging with a multi-country comparison","volume":"11","author":"Son","year":"2024","journal-title":"J Prev Alzheimers Dis"},{"issue":"10452","key":"2025052523413235500_fcaf163-B5","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","article-title":"Dementia prevention, intervention, and care: 2024 report of the lancet standing commission","volume":"404","author":"Livingston","year":"2024","journal-title":"Lancet"},{"issue":"3","key":"2025052523413235500_fcaf163-B6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J Intern Med"},{"issue":"3","key":"2025052523413235500_fcaf163-B7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1474-4422(19)30368-0","article-title":"The characterisation of subjective cognitive decline","volume":"19","author":"Jessen","year":"2020","journal-title":"Lancet Neurol"},{"issue":"6","key":"2025052523413235500_fcaf163-B8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/acps.12336","article-title":"Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: Meta-analysis","volume":"130","author":"Mitchell","year":"2014","journal-title":"Acta Psychiatr Scand"},{"key":"2025052523413235500_fcaf163-B9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fnagi.2019.00007","article-title":"Amyloid-\u03b2 load is related to worries, but not to severity of cognitive complaints in individuals with subjective cognitive decline: The SCIENCe project","volume":"11","author":"Verfaillie","year":"2019","journal-title":"Front Aging Neurosci"},{"issue":"12","key":"2025052523413235500_fcaf163-B10","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jamaneurol.2017.2216","article-title":"Region-specific association of subjective cognitive decline with tauopathy independent of global \u03b2-amyloid burden","volume":"74","author":"Buckley","year":"2017","journal-title":"JAMA Neurol."},{"issue":"4","key":"2025052523413235500_fcaf163-B11","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/ana.25189","article-title":"Memory complaints, dementia, and neuropathology in older blacks and whites","volume":"83","author":"Arvanitakis","year":"2018","journal-title":"Ann Neurol"},{"issue":"2","key":"2025052523413235500_fcaf163-B12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jalz.2015.05.017","article-title":"Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment","volume":"12","author":"Ismail","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"3","key":"2025052523413235500_fcaf163-B13","doi-asserted-by":"crossref","first-page":"40123","DOI":"10.4088\/JCP.21m14105","article-title":"Prevalence, clinical correlates, cognitive trajectories, and dementia risk associated with mild behavioral impairment in asians","volume":"83","author":"Kan","year":"2022","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"2025052523413235500_fcaf163-B14","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-201184","article-title":"Mild behavioral impairment and subjective cognitive decline predict cognitive and functional decline","volume":"80","author":"Ismail","year":"2021","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"2025052523413235500_fcaf163-B15","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1002\/alz.12519","article-title":"Mild behavioral impairment is associated with progression to Alzheimer's disease: A clinicopathological study","volume":"18","author":"Ruthirakuhan","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"1","key":"2025052523413235500_fcaf163-B16","doi-asserted-by":"crossref","first-page":"e12370","DOI":"10.1002\/trc2.12370","article-title":"Apathy and APOE in mild behavioral impairment, and risk for incident dementia","volume":"8","author":"Vellone","year":"2022","journal-title":"Alzheimers Dement (N Y)"},{"issue":"1","key":"2025052523413235500_fcaf163-B17","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/glad098","article-title":"Impact of mild behavioral impairment on longitudinal changes in cognition","volume":"79","author":"Rouse","year":"2024","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"4","key":"2025052523413235500_fcaf163-B18","doi-asserted-by":"crossref","first-page":"e12483","DOI":"10.1002\/dad2.12483","article-title":"Persistence of neuropsychiatric symptoms and dementia prognostication: A comparison of three operational case definitions of mild behavioral impairment","volume":"15","author":"Guan","year":"2023","journal-title":"Alzheimers Dement (Amst)"},{"issue":"21","key":"2025052523413235500_fcaf163-B19","doi-asserted-by":"crossref","first-page":"e2132","DOI":"10.1212\/WNL.0000000000200256","article-title":"Progression to dementia or reversion to normal cognition in mild cognitive impairment as a function of late onset neuropsychiatric symptoms","volume":"98","author":"McGirr","year":"2022","journal-title":"Neurology"},{"issue":"1","key":"2025052523413235500_fcaf163-B20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13024-023-00631-6","article-title":"Optimizing detection of Alzheimer's disease in mild cognitive impairment: A 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO","volume":"18","author":"Ismail","year":"2023","journal-title":"Mol Neurodegener"},{"issue":"13","key":"2025052523413235500_fcaf163-B21","doi-asserted-by":"crossref","first-page":"e70016","DOI":"10.1002\/hbm.70016","article-title":"Neuropsychiatric symptoms: Risk factor or disease marker? A study of structural imaging biomarkers of Alzheimer's disease and incident cognitive decline","volume":"45","author":"Guan","year":"2024","journal-title":"Hum Brain Mapp"},{"key":"2025052523413235500_fcaf163-B22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jad.2023.03.074","article-title":"Effects of race, baseline cognition, and APOE on the association of affective dysregulation with incident dementia: A longitudinal study of dementia-free older adults","volume":"332","author":"Ebrahim","year":"2023","journal-title":"J Affect Disord"},{"issue":"4","key":"2025052523413235500_fcaf163-B23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s44220-023-00043-x","article-title":"A longitudinal study of late-life psychosis and incident dementia and the potential effects of race and cognition","volume":"1","author":"Ismail","year":"2023","journal-title":"Nat Ment Health."},{"issue":"7","key":"2025052523413235500_fcaf163-B24","doi-asserted-by":"crossref","first-page":"e683","DOI":"10.1212\/WNL.0000000000201517","article-title":"Plasma phosphorylated tau at threonine 181 and neuropsychiatric symptoms in preclinical and prodromal Alzheimer disease","volume":"100","author":"Ghahremani","year":"2023","journal-title":"Neurology"},{"key":"2025052523413235500_fcaf163-B25","doi-asserted-by":"crossref","first-page":"111743","DOI":"10.1016\/j.exger.2022.111743","article-title":"Dual-task gait and mild behavioral impairment: The interface between non-cognitive dementia markers","volume":"162","author":"Guan","year":"2022","journal-title":"Exp Gerontol"},{"issue":"4","key":"2025052523413235500_fcaf163-B26","doi-asserted-by":"crossref","first-page":"e12424","DOI":"10.1002\/trc2.12424","article-title":"Temporal associations between treated and untreated hearing loss and mild behavioral impairment in older adults without dementia","volume":"9","author":"Gosselin","year":"2023","journal-title":"Alzheimer's & Dementia: Translational Research & Clinical Interventions"},{"issue":"1","key":"2025052523413235500_fcaf163-B27","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3233\/JAD-210037","article-title":"The association between diabetes Mellitus and mild behavioral impairment among mild cognitive impairment: Findings from Singapore","volume":"82","author":"Soo","year":"2021","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"2025052523413235500_fcaf163-B28","doi-asserted-by":"crossref","first-page":"692","DOI":"10.14283\/jpad.2022.61","article-title":"Sex moderates the association between frailty and mild behavioral impairment","volume":"9","author":"Guan","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"2025052523413235500_fcaf163-B29","doi-asserted-by":"crossref","first-page":"510\u2013","DOI":"10.1186\/s12877-020-01903-2","article-title":"Mild behavioral impairment is related to frailty in non-dementia older adults: A cross-sectional study","volume":"20","author":"Fan","year":"2020","journal-title":"BMC Geriatr"},{"issue":"4","key":"2025052523413235500_fcaf163-B30","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.3233\/JAD-230923","article-title":"Relationship between loneliness and mild behavioral impairment: Validation of the Japanese version of the MBI checklist and a cross-sectional study","volume":"97","author":"Matsuoka","year":"2024","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"2025052523413235500_fcaf163-B31","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3233\/ADR-230086","article-title":"Longitudinal associations between mild behavioral impairment, sleep disturbance, and progression to dementia","volume":"7","author":"Mudalige","year":"2023","journal-title":"J Alzheimers Dis Rep"},{"issue":"10","key":"2025052523413235500_fcaf163-B32","doi-asserted-by":"crossref","first-page":"e6153","DOI":"10.1002\/gps.6153","article-title":"Mild behavioral impairment and quality of life in community dwelling older adults","volume":"39","author":"Warring","year":"2024","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"2025052523413235500_fcaf163-B33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.14283\/jpad.2023.125","article-title":"CTAD task force paper: Neuropsychiatric symptoms in AD: Clinical trials targeting mild behavioral impairment: A report from the international CTAD task force","volume":"11","author":"Soto","year":"2024","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"2025052523413235500_fcaf163-B34","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jalz.2018.07.222","article-title":"Vascular dysfunction-the disregarded partner of Alzheimer's disease","volume":"15","author":"Sweeney","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"3","key":"2025052523413235500_fcaf163-B35","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3233\/JAD-180285","article-title":"Subjective cognitive decline is associated with greater white matter hyperintensity volume","volume":"66","author":"Van Rooden","year":"2018","journal-title":"J Alzheimers Dis."},{"issue":"7","key":"2025052523413235500_fcaf163-B36","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/geronb\/gbz120","article-title":"Evidence of a relation between hippocampal volume, white matter hyperintensities, and cognition in subjective cognitive decline and mild cognitive impairment","volume":"75","author":"Caillaud","year":"2020","journal-title":"The Journals of Gerontology: Series B"},{"issue":"1","key":"2025052523413235500_fcaf163-B37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11357-022-00684-3","article-title":"White matter hyperintensity load varies depending on subjective cognitive decline criteria","volume":"45","author":"Morrison","year":"2023","journal-title":"GeroScience"},{"key":"2025052523413235500_fcaf163-B38","first-page":"100028","article-title":"White matter hyperintensities and mild behavioral impairment: Findings from the MEMENTO cohort study","volume":"2","author":"Miao","year":"2021","journal-title":"Cereb Circ Cogn Behav"},{"issue":"51","key":"2025052523413235500_fcaf163-B39","doi-asserted-by":"crossref","first-page":"e28229","DOI":"10.1097\/MD.0000000000028229","article-title":"Risk factors of cerebral small vessel disease: A systematic review and meta-analysis","volume":"100","author":"Wang","year":"2021","journal-title":"Medicine (Baltimore)."},{"issue":"1","key":"2025052523413235500_fcaf163-B40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jamainternmed.2016.6807","article-title":"A comparison of the prevalence of dementia in the United States in 2000 and 2012","volume":"177","author":"Langa","year":"2017","journal-title":"JAMA Intern Med."},{"key":"2025052523413235500_fcaf163-B41","doi-asserted-by":"crossref","first-page":"l4414","DOI":"10.1136\/bmj.l4414","article-title":"Association of ideal cardiovascular health at age 50 with incidence of dementia: 25 year follow-up of whitehall II cohort study","volume":"366","author":"Sabia","year":"2019","journal-title":"BMJ"},{"issue":"12","key":"2025052523413235500_fcaf163-B42","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/alz.12359","article-title":"Association of Life's Simple 7 with incident dementia and its modification by the apolipoprotein E genotype","volume":"17","author":"Guo","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"11","key":"2025052523413235500_fcaf163-B43","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41582-018-0070-3","article-title":"Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease","volume":"14","author":"Kivipelto","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"2025052523413235500_fcaf163-B44","doi-asserted-by":"crossref","first-page":"100207","DOI":"10.1016\/j.ahr.2024.100207","article-title":"The Canadian platform for research online to investigate health, quality of life, cognition, behaviour, function, and caregiving in aging (CAN-PROTECT): Study protocol, platform description, and preliminary analyses","volume":"4","author":"Ismail","year":"2024","journal-title":"Aging Health Res."},{"key":"2025052523413235500_fcaf163-B45","article-title":"BMI classification percentile and cut off points","author":"Weir","year":"2019","journal-title":"StatPearls"},{"issue":"3","key":"2025052523413235500_fcaf163-B46","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/WAD.0000000000000450","article-title":"The measurement of Everyday Cognition (ECog): Revisions and updates","volume":"35","author":"Farias","year":"2021","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"4","key":"2025052523413235500_fcaf163-B47","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1212\/WNL.0000000000005863","article-title":"Subjective cognitive decline and risk of MCI: The mayo clinic study of aging","volume":"91","author":"van Harten","year":"2018","journal-title":"Neurology"},{"issue":"6","key":"2025052523413235500_fcaf163-B48","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1017\/S1041610219001200","article-title":"Profile of mild behavioral impairment and factor structure of the mild behavioral impairment checklist in cognitively normal older adults","volume":"32","author":"Creese","year":"2020","journal-title":"Int Psychogeriatr"},{"issue":"3","key":"2025052523413235500_fcaf163-B49","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3233\/JAD-160979","article-title":"The mild behavioral impairment checklist (MBI-C): A rating scale for neuropsychiatric symptoms in Pre-dementia populations","volume":"56","author":"Ismail","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"2025052523413235500_fcaf163-B50","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1017\/S1041610221002878","article-title":"Cognitive profile of people with mild behavioral impairment in brain health registry participants","volume":"35","author":"Kassam","year":"2023","journal-title":"Int Psychogeriatr"},{"issue":"2","key":"2025052523413235500_fcaf163-B51","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3390\/ijms23020786","article-title":"Metabolic syndrome: Updates on pathophysiology and management in 2021","volume":"23","author":"Fahed","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2025052523413235500_fcaf163-B52","doi-asserted-by":"crossref","first-page":"7206","DOI":"10.1038\/s41598-021-86667-4","article-title":"The dynamic association between body mass index and cognition from midlife through late-life, and the effect of sex and genetic influences","volume":"11","author":"Karlsson","year":"2021","journal-title":"Sci Rep"},{"issue":"10","key":"2025052523413235500_fcaf163-B53","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/jamaneurol.2014.1646","article-title":"Midlife hypertension and 20-year cognitive change: The atherosclerosis risk in communities neurocognitive study","volume":"71","author":"Gottesman","year":"2014","journal-title":"JAMA Neurol."},{"issue":"5","key":"2025052523413235500_fcaf163-B54","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1445-5994.2012.02758.x","article-title":"Diabetes as a risk factor for dementia and mild cognitive impairment: A meta-analysis of longitudinal studies","volume":"42","author":"Cheng","year":"2012","journal-title":"Intern Med J"},{"issue":"4","key":"2025052523413235500_fcaf163-B55","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1176\/appi.ajp.2014.14070878","article-title":"Modifiable predictors of dementia in mild cognitive impairment: A systematic review and meta-analysis","volume":"172","author":"Cooper","year":"2015","journal-title":"Am J Psychiatry"},{"issue":"9","key":"2025052523413235500_fcaf163-B56","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.jamda.2021.02.033","article-title":"Diabetes and prediabetes inhibit reversion from mild cognitive impairment to normal cognition","volume":"22","author":"Makino","year":"2021","journal-title":"J Am Med Dir Assoc"},{"key":"2025052523413235500_fcaf163-B57","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jad.2022.07.008","article-title":"Modifiable risk factors for incident dementia and cognitive impairment: An umbrella review of evidence","volume":"314","author":"Zhang","year":"2022","journal-title":"J Affect Disord"},{"key":"2025052523413235500_fcaf163-B58","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s10072-019-03750-5","article-title":"Multi-angles of smoking and mild cognitive impairment: Is the association mediated by sleep duration?","volume":"40","author":"Hu","year":"2019","journal-title":"Neurol Sci"},{"issue":"1","key":"2025052523413235500_fcaf163-B59","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3233\/JAD-220501","article-title":"Relation between smoking Status and subjective cognitive decline in middle age and older adults: A cross-sectional analysis of 2019 behavioral risk factor surveillance system data","volume":"91","author":"Rajczyk","year":"2023","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"2025052523413235500_fcaf163-B60","doi-asserted-by":"crossref","first-page":"e0118333","DOI":"10.1371\/journal.pone.0118333","article-title":"Smoking is associated with an increased risk of dementia: A meta-analysis of prospective cohort studies with investigation of potential effect modifiers","volume":"10","author":"Zhong","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"2025052523413235500_fcaf163-B61","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/aje\/kwm116","article-title":"Smoking as a risk factor for dementia and cognitive decline: A meta-analysis of prospective studies","volume":"166","author":"Anstey","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"1","key":"2025052523413235500_fcaf163-B62","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13293-022-00425-3","article-title":"Overall and sex-specific risk factors for subjective cognitive decline: Findings from the 2015\u20132018 behavioral risk factor surveillance system survey","volume":"13","author":"Schliep","year":"2022","journal-title":"Biol Sex Differ"},{"issue":"1","key":"2025052523413235500_fcaf163-B63","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/jgs.12067","article-title":"High blood pressure and cognitive decline in mild cognitive impairment","volume":"61","author":"Goldstein","year":"2013","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"2025052523413235500_fcaf163-B64","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.amjmed.2009.08.015","article-title":"Higher incidence of mild cognitive impairment in familial hypercholesterolemia","volume":"123","author":"Zamb\u00f3n","year":"2010","journal-title":"Am J Med."},{"issue":"7","key":"2025052523413235500_fcaf163-B65","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1474-4422(10)70104-6","article-title":"Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic challenges","volume":"9","author":"Pantoni","year":"2010","journal-title":"Lancet Neurol."},{"issue":"7","key":"2025052523413235500_fcaf163-B66","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S1474-4422(19)30079-1","article-title":"Small vessel disease: Mechanisms and clinical implications","volume":"18","author":"Wardlaw","year":"2019","journal-title":"Lancet Neurol."},{"issue":"1","key":"2025052523413235500_fcaf163-B67","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ana.25380","article-title":"Attributable risk of Alzheimer's dementia attributed to age-related neuropathologies","volume":"85","author":"Boyle","year":"2019","journal-title":"Ann Neurol"},{"issue":"9","key":"2025052523413235500_fcaf163-B68","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/jamaneurol.2018.1123","article-title":"Interactive associations of vascular risk and \u03b2-amyloid burden with cognitive decline in clinically normal elderly individuals: Findings from the harvard aging brain study","volume":"75","author":"Rabin","year":"2018","journal-title":"JAMA Neurol."},{"issue":"1","key":"2025052523413235500_fcaf163-B69","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13195-021-00949-7","article-title":"Mild behavioral impairment: Measurement and clinical correlates of a novel marker of preclinical Alzheimer's disease","volume":"14","author":"Creese","year":"2022","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"2025052523413235500_fcaf163-B70","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/08919887211016068","article-title":"Plasma beta-amyloid in mild behavioural impairment\u2014Neuropsychiatric symptoms on the Alzheimer's Continuum","volume":"35","author":"Miao","year":"2022","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"1","key":"2025052523413235500_fcaf163-B71","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/alz.12007","article-title":"Mild behavioral impairment is associated with beta-amyloid but not tau or neurodegeneration in cognitively intact elderly individuals","volume":"16","author":"Lussier","year":"2020","journal-title":"Alzheimers Dement"},{"issue":"1","key":"2025052523413235500_fcaf163-B72","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41398-021-01206-z","article-title":"Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer's disease","volume":"11","author":"Johansson","year":"2021","journal-title":"Transl Psychiatry"},{"key":"2025052523413235500_fcaf163-B73","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3233\/JAD-200011","article-title":"Plasma neurofilament light: A marker of neurodegeneration in mild behavioral impairment","volume":"76","author":"Naude","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"2025052523413235500_fcaf163-B74","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neurobiolaging.2024.02.006","article-title":"Tau-PET in early cortical Alzheimer brain regions in relation to mild behavioral impairment in older adults with either normal cognition or mild cognitive impairment","volume":"138","author":"Naude","year":"2024","journal-title":"Neurobiol Aging"},{"issue":"4","key":"2025052523413235500_fcaf163-B75","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.3233\/JAD-230898","article-title":"Mild behavioral impairment and cerebrovascular profiles are associated with early cognitive impairment in a community-based southeast Asian cohort","volume":"97","author":"Leow","year":"2024","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"2025052523413235500_fcaf163-B76","doi-asserted-by":"crossref","first-page":"e0234514","DOI":"10.1371\/journal.pone.0234514","article-title":"Behavioural issues in late life may be the precursor of dementia- A cross sectional evidence from memory clinic of AIIMS, India","volume":"15","author":"Rao","year":"2020","journal-title":"PLoS One"},{"key":"2025052523413235500_fcaf163-B77","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00401-017-1717-7","article-title":"Impact of multiple pathologies on the threshold for clinically overt dementia","volume":"134","author":"Kapasi","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"8","key":"2025052523413235500_fcaf163-B78","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.1016\/S2666-7568(21)00150-1","article-title":"Blood cholesterol and risk of dementia in more than 1\u00b7 8 million people over two decades: A retrospective cohort study","volume":"2","author":"Iwagami","year":"2021","journal-title":"Lancet Healthy Longev."},{"issue":"2","key":"2025052523413235500_fcaf163-B79","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jamainternmed.2021.7009","article-title":"Association of systolic blood pressure with dementia risk and the role of age, U-shaped associations, and mortality","volume":"182","author":"van Dalen","year":"2022","journal-title":"JAMA Intern Med."},{"issue":"2","key":"2025052523413235500_fcaf163-B80","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/YCO.0000000000000684","article-title":"Hypertension and Alzheimer's disease: Is the picture any clearer?","volume":"34","author":"Lennon","year":"2021","journal-title":"Curr Opin Psychiatry."},{"issue":"1","key":"2025052523413235500_fcaf163-B81","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.gerinurse.2020.08.016","article-title":"Factors predicting episodic memory changes in older adults with subjective cognitive decline: A longitudinal observational study","volume":"42","author":"Ahn","year":"2021","journal-title":"Geriatr Nurs"},{"issue":"1","key":"2025052523413235500_fcaf163-B82","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1192\/bjp.2019.156","article-title":"Trajectory of blood pressure, body mass index, cholesterol and incident dementia: Systematic review","volume":"216","author":"Peters","year":"2020","journal-title":"The British Journal of Psychiatry"}],"container-title":["Brain Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/braincomms\/advance-article-pdf\/doi\/10.1093\/braincomms\/fcaf163\/63021902\/fcaf163.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/7\/3\/fcaf163\/63021902\/fcaf163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/7\/3\/fcaf163\/63021902\/fcaf163.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T03:41:50Z","timestamp":1748230910000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/braincomms\/article\/doi\/10.1093\/braincomms\/fcaf163\/8121185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":82,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,4,30]]}},"URL":"https:\/\/doi.org\/10.1093\/braincomms\/fcaf163","relation":{},"ISSN":["2632-1297"],"issn-type":[{"value":"2632-1297","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"fcaf163"}}